X

Other Industries

Aurora Cannabis reiterates revenue outlook for Q4, FY19

Cannabis producer Aurora Cannabis (NYSE: ACB) reiterated its production and revenue guidance for the fourth quarter and fiscal 2019 after…

Alnylam Pharmaceuticals posts narrower-than-expected Q2 loss

Alnylam Pharmaceuticals (NASDAQ: ALNY) reported a wider loss in the second quarter of 2019 due to higher costs and expenses.…

Bausch Health stock rises on guidance hike

Bausch Health Companies Inc. (NYSE: BHC) said its revenues for the second quarter edged up 1% to $2.15 billion, in…

Vericel reports Q2 earnings beat, raises outlook

Vericel Corporation (NASDAQ: VCEL) reported better-than-expected results in the second quarter aided by strong growth from both of its products.…

Chesapeake Energy swings to profit in Q2

Chesapeake Energy Corporation (NYSE: CHK) swung to profit in the second quarter from a loss last year, driven by higher oil…

Allergan tops Q2 views; lifts 2019 revenue outlook

Allergan plc (NYSE: AGN) surpassed market's expecations for Q2. The company also lifted its revenue outlook for full-year 2019. Non-GAAP…

Plug Power Q2 loss narrows on strong revenue growth, beats Steet view

Picture Courtesy: Plug Power Alternative energy technology company Plug Power (NASDAQ: PLUG) reported a narrower net loss for the second…

Regeneron Q2 earnings, revenue top expectations on strong product sales

Regeneron Pharmaceuticals (NASDAQ: REGN) reported an increase in earnings for the second quarter, when revenues grew by 20% helped by…

Marriott Q2 earnings in line with estimates, but revenue fails to impress

Marriott International (NASDAQ: MAR) stock slipped about 3% after the bell as the second quarter earnings came in line with…

Earnings preview: Teva’s struggles might not end in Q2

Teva Pharmaceuticals (NYSE: TEVA) is scheduled to report second quarter 2019 earnings results on Wednesday, August 7, before market open.…